Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study - Cappuzzo,F.; Ciuleanu,T.; Stelmakh,L. (Lancet Oncol, 2010)